ERAS vs SNPS · $4.13B cap vs P/E 63, rev $7.16B
Erasca Inc (ERAS) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Erasca Inc (ERAS) is a biotechnology company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
ERAS does not have a complete income-statement cache yet.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
ERAS currently screens at market cap $4.13B. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the ERAS and SNPS stock pages for the full models.
Not investment advice.